In a new report, UBS analyst Matthew Roden discusses the firm’s bullish outlook for biotech stocks. Biotech has had a strong run so far this year, but Roden still sees gas in the tank for several names.
Three Drivers
UBS sees three drivers for biotech outperformance in the second half of the year. First, the firm is predicting that most of the larger names should beat consensus earnings estimates in Q3 and Q4.
Second, the firm sees big catalysts on the way for several names in the second half of the year that could drive prices higher. The report names Incyte Corp INCY 5.33%, BioMartin Pharmaceutical Inc BMRN 2.47%, Prothena Corp Plc PRTA 5.18%, Puma Biotechnology Inc PBYI 3.36%, Achillion Pharmaceuticals Inc ACHN 1.05% and Medivation Inc MDVN 2.22% as second-half catalyst plays.
Finally, Roden mentions the continuing appetite for biotech M&A as a share price driver for the rest of the year. He believes that large cap biotech and pharma companies are still looking to make asset acquisitions, and share prices will likely remain elevated in that type of environment.
Buying Opportunity
Biotech stocks have been hit…
Click here to continue reading
Want to learn more about how to profit off the stock market? Or maybe you just want to be able to look sophisticated in front of your coworkers when they ask you what you are reading on your Kindle, and you’d prefer to tell them “Oh, I’m just reading a book about stock market analysis,” rather than the usual “Oh, I’m just looking at pics of my ex-girlfriend on Facebook.” For these reasons and more, check out my book, Beating Wall Street with Common Sense. I don’t have a degree in finance; I have a degree in neuroscience. You don’t have to predict what stocks will do if you can predict what traders will do and be one step ahead of them. I made a 400% return in the stock market over five years using only basic principles of psychology and common sense. Beating Wall Street with Common Sense is now available on Amazon, and tradingcommonsense.com is always available on your local internet!
